Do analysts recommend ADVB or EUDA?

EUDA Health has a consensus price target of $55.00, indicating a potential upside of 279.76%. Given EUDA Health's stronger consensus rating and higher possible upside, analysts plainly believe EUDA Health is more favorable than Advanced Biomed. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Advanced Biomed 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 EUDA Health 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has better earnings & valuation, ADVB or EUDA?

EUDA Health has higher revenue and earnings than Advanced Biomed. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Advanced Biomed N/A N/A -$3.26M $4.82 1.85 EUDA Health $6.82M 6.35 -$2.77M N/A N/A

Is ADVB or EUDA more profitable?

Advanced Biomed's return on equity of 87.74% beat EUDA Health's return on equity. Company Net Margins Return on Equity Return on Assets Advanced Biomed N/A 87.74% 64.49% EUDA Health N/A N/A N/A

Does the media refer more to ADVB or EUDA?

In the previous week, Advanced Biomed had 5 more articles in the media than EUDA Health. MarketBeat recorded 6 mentions for Advanced Biomed and 1 mentions for EUDA Health. Advanced Biomed's average media sentiment score of 0.74 beat EUDA Health's score of 0.00 indicating that Advanced Biomed is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Advanced Biomed 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive EUDA Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend ADVB or MRAI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Advanced Biomed 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Marpai 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is ADVB or MRAI more profitable?

Advanced Biomed has a net margin of 0.00% compared to Marpai's net margin of -85.70%. Advanced Biomed's return on equity of 87.74% beat Marpai's return on equity. Company Net Margins Return on Equity Return on Assets Advanced Biomed N/A 87.74% 64.49% Marpai -85.70% N/A -100.23%

Does the media refer more to ADVB or MRAI?

In the previous week, Advanced Biomed had 5 more articles in the media than Marpai. MarketBeat recorded 6 mentions for Advanced Biomed and 1 mentions for Marpai. Advanced Biomed's average media sentiment score of 0.74 beat Marpai's score of 0.00 indicating that Advanced Biomed is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Advanced Biomed 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Marpai 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate CCM or ADVB?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Concord Medical Services 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Advanced Biomed 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation & earnings, CCM or ADVB?

Advanced Biomed has lower revenue, but higher earnings than Concord Medical Services. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Concord Medical Services $65.85M 0.27 -$13.27M N/A N/A Advanced Biomed N/A N/A -$3.26M $4.82 1.85

Is CCM or ADVB more profitable?

Advanced Biomed's return on equity of 87.74% beat Concord Medical Services' return on equity. Company Net Margins Return on Equity Return on Assets Concord Medical Services N/A N/A N/A Advanced Biomed N/A 87.74% 64.49%

Do analysts rate ADVB or BMGL?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Advanced Biomed 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Basel Medical Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings and valuation, ADVB or BMGL?

Advanced Biomed has higher earnings, but lower revenue than Basel Medical Group. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Advanced Biomed N/A N/A -$3.26M $4.82 1.85 Basel Medical Group $8.90M 0.94 -$9.50M N/A N/A

Is ADVB or BMGL more profitable?

Advanced Biomed's return on equity of 87.74% beat Basel Medical Group's return on equity. Company Net Margins Return on Equity Return on Assets Advanced Biomed N/A 87.74% 64.49% Basel Medical Group N/A N/A N/A

Do analysts rate BRTX or ADVB?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biorestorative Therapies 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Advanced Biomed 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media prefer BRTX or ADVB?

In the previous week, Advanced Biomed had 4 more articles in the media than Biorestorative Therapies. MarketBeat recorded 6 mentions for Advanced Biomed and 2 mentions for Biorestorative Therapies. Advanced Biomed's average media sentiment score of 0.74 beat Biorestorative Therapies' score of 0.00 indicating that Advanced Biomed is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Biorestorative Therapies 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Advanced Biomed 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Trading of Advanced Biomed was halted at 03:23 PM EST due to "LULD Pause".

Advanced Biomed (ADVB) Competitors

$8.90 +3.87 (+76.94%)

Closing price 04:00 PM Eastern

Extended Trading

$11.35 +2.45 (+27.54%)

As of 08:00 PM Eastern

Compare

ADVB vs. EUDA, MRAI, CCM, BMGL, and BRTX

Should you buy Advanced Biomed stock or one of its competitors? MarketBeat compares Advanced Biomed with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Advanced Biomed include EUDA Health (EUDA), Marpai (MRAI), Concord Medical Services (CCM), Basel Medical Group (BMGL), and Biorestorative Therapies (BRTX). These companies are all part of the "healthcare" industry.

How does Advanced Biomed compare to EUDA Health?

Advanced Biomed (NASDAQ:ADVB) and EUDA Health (NASDAQ:EUDA) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, earnings, profitability, media sentiment, analyst recommendations, risk and institutional ownership.

4.4% of EUDA Health shares are held by institutional investors. 27.0% of Advanced Biomed shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Advanced Biomed's return on equity of 87.74% beat EUDA Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Advanced Biomed	N/A	87.74%	64.49%
EUDA Health	N/A	N/A	N/A

Advanced Biomed has a beta of 0.52, meaning that its stock price is 48% less volatile than the broader market. Comparatively, EUDA Health has a beta of 0.68, meaning that its stock price is 32% less volatile than the broader market.

EUDA Health has a consensus price target of $55.00, indicating a potential upside of 279.76%. Given EUDA Health's stronger consensus rating and higher possible upside, analysts plainly believe EUDA Health is more favorable than Advanced Biomed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Advanced Biomed	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
EUDA Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

EUDA Health has higher revenue and earnings than Advanced Biomed.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Advanced Biomed	N/A	N/A	-$3.26M	$4.82	1.85
EUDA Health	$6.82M	6.35	-$2.77M	N/A	N/A

In the previous week, Advanced Biomed had 5 more articles in the media than EUDA Health. MarketBeat recorded 6 mentions for Advanced Biomed and 1 mentions for EUDA Health. Advanced Biomed's average media sentiment score of 0.74 beat EUDA Health's score of 0.00 indicating that Advanced Biomed is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Advanced Biomed	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
EUDA Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

EUDA Health beats Advanced Biomed on 7 of the 12 factors compared between the two stocks.

How does Advanced Biomed compare to Marpai?

Advanced Biomed (NASDAQ:ADVB) and Marpai (NASDAQ:MRAI) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, earnings, profitability, dividends, risk, analyst recommendations and institutional ownership.

In the previous week, Advanced Biomed had 5 more articles in the media than Marpai. MarketBeat recorded 6 mentions for Advanced Biomed and 1 mentions for Marpai. Advanced Biomed's average media sentiment score of 0.74 beat Marpai's score of 0.00 indicating that Advanced Biomed is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Advanced Biomed	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Marpai	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Advanced Biomed	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Marpai	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Advanced Biomed has a net margin of 0.00% compared to Marpai's net margin of -85.70%. Advanced Biomed's return on equity of 87.74% beat Marpai's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Advanced Biomed	N/A	87.74%	64.49%
Marpai	-85.70%	N/A	-100.23%

Advanced Biomed has a beta of 0.52, meaning that its stock price is 48% less volatile than the broader market. Comparatively, Marpai has a beta of 4.92, meaning that its stock price is 392% more volatile than the broader market.

49.8% of Marpai shares are held by institutional investors. 27.0% of Advanced Biomed shares are held by insiders. Comparatively, 46.1% of Marpai shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Advanced Biomed has higher earnings, but lower revenue than Marpai. Marpai is trading at a lower price-to-earnings ratio than Advanced Biomed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Advanced Biomed	N/A	N/A	-$3.26M	$4.82	1.85
Marpai	$34.87M	1.72	-$28.75M	-$0.87	N/A

Summary

Advanced Biomed beats Marpai on 9 of the 13 factors compared between the two stocks.

How does Advanced Biomed compare to Concord Medical Services?

Concord Medical Services (NYSE:CCM) and Advanced Biomed (NASDAQ:ADVB) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, risk, analyst recommendations and media sentiment.

In the previous week, Advanced Biomed had 6 more articles in the media than Concord Medical Services. MarketBeat recorded 6 mentions for Advanced Biomed and 0 mentions for Concord Medical Services. Advanced Biomed's average media sentiment score of 0.74 beat Concord Medical Services' score of 0.00 indicating that Advanced Biomed is being referred to more favorably in the news media.

Company	Overall Sentiment
Concord Medical Services	Neutral
Advanced Biomed	Positive

Advanced Biomed's return on equity of 87.74% beat Concord Medical Services' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Concord Medical Services	N/A	N/A	N/A
Advanced Biomed	N/A	87.74%	64.49%

Advanced Biomed has lower revenue, but higher earnings than Concord Medical Services.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Concord Medical Services	$65.85M	0.27	-$13.27M	N/A	N/A
Advanced Biomed	N/A	N/A	-$3.26M	$4.82	1.85

Concord Medical Services has a beta of -0.97, indicating that its stock price is 197% less volatile than the broader market. Comparatively, Advanced Biomed has a beta of 0.52, indicating that its stock price is 48% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Concord Medical Services	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Advanced Biomed	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Advanced Biomed beats Concord Medical Services on 6 of the 7 factors compared between the two stocks.

How does Advanced Biomed compare to Basel Medical Group?

Advanced Biomed (NASDAQ:ADVB) and Basel Medical Group (NASDAQ:BMGL) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings.

Advanced Biomed's return on equity of 87.74% beat Basel Medical Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Advanced Biomed	N/A	87.74%	64.49%
Basel Medical Group	N/A	N/A	N/A

Advanced Biomed has higher earnings, but lower revenue than Basel Medical Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Advanced Biomed	N/A	N/A	-$3.26M	$4.82	1.85
Basel Medical Group	$8.90M	0.94	-$9.50M	N/A	N/A

Advanced Biomed has a beta of 0.52, meaning that its stock price is 48% less volatile than the broader market. Comparatively, Basel Medical Group has a beta of 0.15, meaning that its stock price is 85% less volatile than the broader market.

In the previous week, Advanced Biomed had 6 more articles in the media than Basel Medical Group. MarketBeat recorded 6 mentions for Advanced Biomed and 0 mentions for Basel Medical Group. Advanced Biomed's average media sentiment score of 0.74 beat Basel Medical Group's score of 0.40 indicating that Advanced Biomed is being referred to more favorably in the media.

Company	Overall Sentiment
Advanced Biomed	Positive
Basel Medical Group	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Advanced Biomed	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Basel Medical Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Advanced Biomed beats Basel Medical Group on 6 of the 7 factors compared between the two stocks.

How does Advanced Biomed compare to Biorestorative Therapies?

Biorestorative Therapies (NASDAQ:BRTX) and Advanced Biomed (NASDAQ:ADVB) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, institutional ownership, analyst recommendations, profitability, risk and earnings.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biorestorative Therapies	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Advanced Biomed	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Biorestorative Therapies has a beta of 0.73, meaning that its share price is 27% less volatile than the broader market. Comparatively, Advanced Biomed has a beta of 0.52, meaning that its share price is 48% less volatile than the broader market.

In the previous week, Advanced Biomed had 4 more articles in the media than Biorestorative Therapies. MarketBeat recorded 6 mentions for Advanced Biomed and 2 mentions for Biorestorative Therapies. Advanced Biomed's average media sentiment score of 0.74 beat Biorestorative Therapies' score of 0.00 indicating that Advanced Biomed is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Biorestorative Therapies	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Advanced Biomed	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

69.4% of Biorestorative Therapies shares are owned by institutional investors. 13.6% of Biorestorative Therapies shares are owned by company insiders. Comparatively, 27.0% of Advanced Biomed shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Advanced Biomed has a net margin of 0.00% compared to Biorestorative Therapies' net margin of -3,088.27%. Advanced Biomed's return on equity of 87.74% beat Biorestorative Therapies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biorestorative Therapies	-3,088.27%	-508.42%	-230.94%
Advanced Biomed	N/A	87.74%	64.49%

Advanced Biomed has lower revenue, but higher earnings than Biorestorative Therapies. Biorestorative Therapies is trading at a lower price-to-earnings ratio than Advanced Biomed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biorestorative Therapies	$360K	22.79	-$14.24M	-$1.07	N/A
Advanced Biomed	N/A	N/A	-$3.26M	$4.82	1.85

Summary

Advanced Biomed beats Biorestorative Therapies on 9 of the 12 factors compared between the two stocks.

Get Advanced Biomed News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ADVB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ADVB vs. The Competition

Export

Metric	Advanced Biomed	Services – Health Industry	Services Sector	NASDAQ Exchange
Market Cap	$8.31M	$2.04B	$17.87B	$12.28B
Dividend Yield	N/A	N/A	5.17%	9.39%
P/E Ratio	1.85	25.49	18.76	23.94
Price / Sales	N/A	8.17	37.65	91.92
Price / Cash	N/A	112.35	80.50	47.25
Price / Book	2.77	29.59	12.43	6.14
Net Income	-$3.26M	-$30.36M	-$15.57M	$331.74M
7 Day Performance	74.51%	4.86%	-1.00%	-1.72%
1 Month Performance	74.51%	9.32%	-1.06%	-1.44%
1 Year Performance	N/A	N/A	-14.49%	16.97%

Advanced Biomed Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ADVB Advanced Biomed	1.2413 of 5 stars	$8.90 +76.9%	N/A	N/A	$8.31M	N/A	1.85	40	News Coverage Short Interest Increase Gap Up Trading Halted High Trading Volume
EUDA EUDA Health	1.7926 of 5 stars	$11.68 +4.5%	$55.00 +370.7%	-81.1%	$33.48M	$6.82M	N/A	2	Gap Up
MRAI Marpai	N/A	$1.20 +60.0%	N/A	+22.7%	$31.93M	$34.87M	N/A	150	News Coverage Gap Up High Trading Volume
CCM Concord Medical Services	0.7307 of 5 stars	$4.50 +3.0%	N/A	-23.5%	$18.97M	$65.85M	N/A	970
BMGL Basel Medical Group	0.7152 of 5 stars	$6.14 -24.4%	N/A	-81.7%	$12.71M	$8.90M	N/A	36

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ADVB) was last updated on 7/20/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Advanced Biomed (ADVB) Competitors

ADVB vs. EUDA, MRAI, CCM, BMGL, and BRTX

How does Advanced Biomed compare to EUDA Health?

Summary

How does Advanced Biomed compare to Marpai?

Summary

How does Advanced Biomed compare to Concord Medical Services?

Summary

How does Advanced Biomed compare to Basel Medical Group?

Summary

How does Advanced Biomed compare to Biorestorative Therapies?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ADVB vs. The Competition

Advanced Biomed Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Advanced Biomed (ADVB) Competitors

ADVB vs. EUDA, MRAI, CCM, BMGL, and BRTX

How does Advanced Biomed compare to EUDA Health?

Do institutionals and insiders have more ownership in ADVB or EUDA?

Is ADVB or EUDA more profitable?

Which has more volatility and risk, ADVB or EUDA?

Do analysts recommend ADVB or EUDA?

Which has better earnings & valuation, ADVB or EUDA?

Does the media refer more to ADVB or EUDA?

Summary

How does Advanced Biomed compare to Marpai?

Does the media refer more to ADVB or MRAI?

Do analysts recommend ADVB or MRAI?

Is ADVB or MRAI more profitable?

Which has more risk & volatility, ADVB or MRAI?

Do institutionals & insiders have more ownership in ADVB or MRAI?

Which has higher valuation & earnings, ADVB or MRAI?

Summary

How does Advanced Biomed compare to Concord Medical Services?

Does the media refer more to CCM or ADVB?

Is CCM or ADVB more profitable?

Which has stronger valuation & earnings, CCM or ADVB?

Which has more risk & volatility, CCM or ADVB?

Do analysts rate CCM or ADVB?

Summary

How does Advanced Biomed compare to Basel Medical Group?

Is ADVB or BMGL more profitable?

Which has preferable earnings and valuation, ADVB or BMGL?

Which has more volatility and risk, ADVB or BMGL?

Does the media refer more to ADVB or BMGL?

Do analysts rate ADVB or BMGL?

Summary

How does Advanced Biomed compare to Biorestorative Therapies?

Do analysts rate BRTX or ADVB?

Which has more risk and volatility, BRTX or ADVB?

Does the media prefer BRTX or ADVB?

Do insiders and institutionals believe in BRTX or ADVB?

Is BRTX or ADVB more profitable?

Which has higher earnings & valuation, BRTX or ADVB?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ADVB vs. The Competition

Advanced Biomed Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools